Compare $CLYM vs $FTH | Chartloom

Compare

$CLYM vs $FTH

Climb Bio Inc · Faeth Therapeutics, Inc

CLYM

Climb Bio Inc

FTH

Faeth Therapeutics, Inc

Compare $CLYM vs $FTH

Comparing Climb Bio Inc and Faeth Therapeutics, Inc

CLYMClimb Bio Inc

FTHFaeth Therapeutics, Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

FTHFaeth Therapeutics, Inc

Market cap

$671M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

79.1%

52W performance

79.1%

FCF yield

-5.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

FTH

Detailed metrics comparison

CLYM

Climb Bio Inc

FTH

Faeth Therapeutics, Inc

Market Cap

CLYM$630M

FTH$671M

Enterprise Value

CLYM$586M

FTH$644M

Price

CLYM$11.00

FTH$26.03

P/E Ratio

CLYMN/A

FTHN/A

P/S Ratio

CLYM0.00x

FTH0.00x

EV/Sales

CLYM0.00x

FTH0.00x

EV/EBITDA

CLYM0.00x

FTH0.00x

P/B Ratio

CLYM2.62x

FTH4.08x

P/FCF Ratio

CLYMN/A

FTHN/A

EV/FCF

CLYM-11.04x

FTH-19.02x

PEG Ratio

CLYMN/A

FTHN/A

Forward P/E (NTM)

CLYMN/A

FTHN/A

Forward P/S (NTM)

CLYMN/A

FTHN/A

Revenue (TTM)

CLYM$0

FTH$0

Revenue Growth (YoY)

CLYMN/A

FTHN/A

Forward Rev Growth

CLYM27.3%

FTH77.6%

Gross Margin (TTM)

CLYM0.0%

FTH0.0%

Operating Margin (TTM)

CLYM0.0%

FTH0.0%

EBITDA Margin (TTM)

CLYM0.0%

FTH0.0%

Net Margin (TTM)

CLYM0.0%

FTH0.0%

FCF Margin (TTM)

CLYMN/A

FTHN/A

Net Income (TTM)

CLYM$-58M

FTH$-196M

FCF (TTM)

CLYM$-53M

FTH$-34M

EPS (TTM)

CLYM-$0.76

FTH-$34.65

ROE (TTM)

CLYM-3179.0%

FTH-18959.0%

ROA (TTM)

CLYM-3079.0%

FTH-17568.0%

ROIC (TTM)

CLYM-3179.0%

FTH-18946.0%

Cash

CLYM$44M

FTH$27M

Debt

CLYM$0

FTH$0

Net Cash/Debt

CLYM$44M

FTH$27M

Current Ratio (TTM)

CLYM31.45x

FTH19.69x

Quick Ratio (TTM)

CLYM30.86x

FTH19.55x

Debt/Equity (TTM)

CLYM0.00x

FTH0.00x

Debt/Assets (TTM)

CLYM0.0%

FTH0.0%

Interest Coverage (TTM)

CLYMN/A

FTHN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

FTH0.00x

Beta

CLYM-0.01

FTH2.05

52W Performance

CLYM511.1%

FTH79.1%

YTD Performance

CLYM193.3%

FTH79.1%

% from 52W High

CLYM-40.0%

FTH-38.2%

% from 52W Low

CLYM572.8%

FTH93.8%

Asset Turnover (TTM)

CLYM0.00x

FTH0.00x

FCF Yield (TTM)

CLYM-8.4%

FTH-5.0%

Earnings Yield (TTM)

CLYM-9.1%

FTH-29.1%

Dividend Yield (TTM)

CLYMN/A

FTHN/A

Rule of 40

CLYM0.0

FTH0.0

EV/GP/RG

CLYMN/A

FTHN/A

Ticker research

View CLYM research View FTH research

Metric	CLYM Climb Bio Inc	FTH Faeth Therapeutics, Inc
Market & Valuation
Market Cap	$630M	$671M
Enterprise Value	$586M	$644M
Price	$11.00	$26.03
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	4.08x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-19.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	27.3%	77.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-196M
FCF (TTM)	$-53M	$-34M
EPS (TTM)	-$0.76	-$34.65
ROE (TTM)	-3179.0%	-18959.0%
ROA (TTM)	-3079.0%	-17568.0%
ROIC (TTM)	-3179.0%	-18946.0%
Financial Health
Cash	$44M	$27M
Debt	$0	$0
Net Cash/Debt	$44M	$27M
Current Ratio (TTM)	31.45x	19.69x
Quick Ratio (TTM)	30.86x	19.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	2.05
52W Performance	511.1%	79.1%
YTD Performance	193.3%	79.1%
% from 52W High	-40.0%	-38.2%
% from 52W Low	572.8%	93.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-5.0%
Earnings Yield (TTM)	-9.1%	-29.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View FTH research

Valuation

P/S Ratio

CLYM

0.00x

FTH

0.00x

EV/FCF

FTH

-19.02x

CLYM

-11.04x

Growth & revenue

Forward Revenue Growth

FTH

77.6%

CLYM

27.3%

Profitability & performance

Gross Margin

CLYM

0.0%

FTH

0.0%

ROE

CLYM

-3179.0%

FTH

-18959.0%

FCF Yield %

FTH

-5.0%

CLYM

-8.4%

52-Week Performance

CLYM

511.1%

FTH

79.1%

Detailed metrics comparison

CLYM

Climb Bio Inc

FTH

Faeth Therapeutics, Inc

Market Cap

CLYM$630M

FTH$671M

Enterprise Value

CLYM$586M

FTH$644M

Price

CLYM$11.00

FTH$26.03

P/E Ratio

CLYMN/A

FTHN/A

P/S Ratio

CLYM0.00x

FTH0.00x

EV/Sales

CLYM0.00x

FTH0.00x

EV/EBITDA

CLYM0.00x

FTH0.00x

P/B Ratio

CLYM2.62x

FTH4.08x

P/FCF Ratio

CLYMN/A

FTHN/A

EV/FCF

CLYM-11.04x

FTH-19.02x

PEG Ratio

CLYMN/A

FTHN/A

Forward P/E (NTM)

CLYMN/A

FTHN/A

Forward P/S (NTM)

CLYMN/A

FTHN/A

Revenue (TTM)

CLYM$0

FTH$0

Revenue Growth (YoY)

CLYMN/A

FTHN/A

Forward Rev Growth

CLYM27.3%

FTH77.6%

Gross Margin (TTM)

CLYM0.0%

FTH0.0%

Operating Margin (TTM)

CLYM0.0%

FTH0.0%

EBITDA Margin (TTM)

CLYM0.0%

FTH0.0%

Net Margin (TTM)

CLYM0.0%

FTH0.0%

FCF Margin (TTM)

CLYMN/A

FTHN/A

Net Income (TTM)

CLYM$-58M

FTH$-196M

FCF (TTM)

CLYM$-53M

FTH$-34M

EPS (TTM)

CLYM-$0.76

FTH-$34.65

ROE (TTM)

CLYM-3179.0%

FTH-18959.0%

ROA (TTM)

CLYM-3079.0%

FTH-17568.0%

ROIC (TTM)

CLYM-3179.0%

FTH-18946.0%

Cash

CLYM$44M

FTH$27M

Debt

CLYM$0

FTH$0

Net Cash/Debt

CLYM$44M

FTH$27M

Current Ratio (TTM)

CLYM31.45x

FTH19.69x

Quick Ratio (TTM)

CLYM30.86x

FTH19.55x

Debt/Equity (TTM)

CLYM0.00x

FTH0.00x

Debt/Assets (TTM)

CLYM0.0%

FTH0.0%

Interest Coverage (TTM)

CLYMN/A

FTHN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

FTH0.00x

Beta

CLYM-0.01

FTH2.05

52W Performance

CLYM511.1%

FTH79.1%

YTD Performance

CLYM193.3%

FTH79.1%

% from 52W High

CLYM-40.0%

FTH-38.2%

% from 52W Low

CLYM572.8%

FTH93.8%

Asset Turnover (TTM)

CLYM0.00x

FTH0.00x

FCF Yield (TTM)

CLYM-8.4%

FTH-5.0%

Earnings Yield (TTM)

CLYM-9.1%

FTH-29.1%

Dividend Yield (TTM)

CLYMN/A

FTHN/A

Rule of 40

CLYM0.0

FTH0.0

EV/GP/RG

CLYMN/A

FTHN/A

Ticker research

View CLYM research View FTH research

Metric	CLYM Climb Bio Inc	FTH Faeth Therapeutics, Inc
Market & Valuation
Market Cap	$630M	$671M
Enterprise Value	$586M	$644M
Price	$11.00	$26.03
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	4.08x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-19.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	27.3%	77.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-196M
FCF (TTM)	$-53M	$-34M
EPS (TTM)	-$0.76	-$34.65
ROE (TTM)	-3179.0%	-18959.0%
ROA (TTM)	-3079.0%	-17568.0%
ROIC (TTM)	-3179.0%	-18946.0%
Financial Health
Cash	$44M	$27M
Debt	$0	$0
Net Cash/Debt	$44M	$27M
Current Ratio (TTM)	31.45x	19.69x
Quick Ratio (TTM)	30.86x	19.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	2.05
52W Performance	511.1%	79.1%
YTD Performance	193.3%	79.1%
% from 52W High	-40.0%	-38.2%
% from 52W Low	572.8%	93.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-5.0%
Earnings Yield (TTM)	-9.1%	-29.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View FTH research